DVDeepanshu Verma

Deepanshu Verma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Deepanshu Verma has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identification and Analysis of Age-Invariant Proteins during Aging in Caenorhabditis elegans

    by Prasad Kasturi, Deepanshu Verma

    Aging is characterized by a progressive decline in organismal fitness and function and is accompanied by loss of proteostasis, the maintenance of a balanced and functional proteome. Although many proteins change in abundance during aging, a subset remains relatively invariant. The contribution of these age-invariant proteins to proteostasis and aging remains unclear. To identify such proteins, we performed a comparative analysis of age-resolved proteomic datasets from wild-type, short-lived, and long-lived mutant C. elegans . Age-invariant proteins were enriched in biosynthetic processes, gene expression, and mRNA metabolism and were predominantly associated with fundamental cellular components. We further analyzed RNA-seq data from wild-type C. elegans and identified transcripts that remained invariant throughout the lifespan or after day 5. Eighty-five genes showed invariant abundance at both RNA and protein levels. Our findings identify a conserved set of age-invariant proteins across strains with distinct lifespans and suggest that validated age-invariant genes may serve as reference controls for biochemical experiments and facilitate the identification of age-associated biomarkers.

  • Extracellular Protein Quality Control in Tau Pathology

    by Prasun Kumar Bhunia, Deepanshu Verma, Priyanka Vimal, Prasad Kasturi

    Aging is the primary risk factor for neurodegenerative diseases that are marked by the accumulation of misfolded and aggregated proteins, commonly known as proteinopathies. Among these, tauopathies are the disorders characterized by abnormal tau protein aggregation that are particularly significant in Alzheimer's Disease. Tau protein undergoes pathological post-translational modifications that promote its aggregation into neurofibrillary tangles, which disrupt neuronal function and cognitive decline. Tau can also spread between neurons via extracellular pathways in a prion-like manner, accelerating disease progression. Extracellular protein quality control (PQC) mechanisms modulate this process by balancing tau stability and clearance. However, age-related decline in these PQC systems enhances toxic tau assemblies, their extracellular accumulation and widespread dissemination. This review explores tau secretion, propagation, and extracellular protein quality control (PQC) in maintaining tau homeostasis, aiming to identify therapeutic strategies for tauopathies.